Stephens Inc. AR reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 14,439 shares ...

Danielle Lloyd has revealed she has been diagnosed with a form of skin cancer and has urged people to see a doctor if they have noticed changes to their skin. As a mother of five, 41-year-old Lloyd ...

H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Replimune Group (NASDAQ:REPL), currently trading at $13.79 with a market cap of $1.06 billion, to $22.00, up from the previous ...

Leerink analyst Jonathan Chang raised the firm’s price target on Replimune (REPL) to $21 from $18 to reflect an increased probability of ...

"The £1.4M raised by LFFM London will have a transformative impact on our mission," said Stephanie Kauffman, president of the Melanoma Research Alliance. "This generous support allows us to ...

A TEEN who's been diagnosed with melanoma twice and had two brain tumours removed, all before the age of 18, has a rare genetic disorder that's been passed down through her family. Ruby-Jo Sneed ...

Scotiabank raised their target price on Castle Biosciences ... Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene ...

The Week is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site. © Future US, Inc. Full 7th Floor, 130 West ...

Hone Health, a telehealth clinic for preventive longevity care, announced Tuesday that it has raised $33 million in Series A funding, which it is using to acquire home health company ivee.

Last year’s golf day had the likes of Peter Sterling and Paul ‘Fatty’ Vautin in attendance, and all money raised will be donated to the Melanoma Institute. Participants will have the ...